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Abstract
Aims: Staging is the gold standard for predicting malignant melanoma outcome but 
changes in its criteria over time indicate ongoing evolution. One notable recent change 
from the 8th edition of the AJCC staging manual was removal of mitotic count. We explore 
the extent that this feature is limited by interobserver error in order to find ways to 
improve its fitness for use should it be revisited in future staging versions. 
Methods and Results: In a cohort of 476 patients with melanoma ≤ 1.0 mm, a mitotic 
count of 0 vs 1 was significant for metastasis-free survival, but not melanoma-specific or 
overall survival. In 10 melanomas that were 0.9 to 1.0 mm thick, the mitotic count intra-
class correlation coefficient for histopathologists was 0.58 (moderate agreement). 
Uniquely, we also assessed agreement for specific putative mitotic figures, identifying 
precise reasons why specific mitotic figures qualified for scoring or elimination. A kappa 
score was 0.54 (moderate agreement). We also gathered data on other staging features. 
Breslow thickness had an intraclass correlation coefficient of 0.41 (moderate agreement) 
and there was a systematic difference between histopathologists across cases (p = 0.04). 
Every case had a range that crossed the AJCC8 0.8 mm pT1a/pT1b staging boundary. 
Ulceration was only identified in 2 out the 10 cases. For ulceration, kappa agreement 
score was 0.31 (fair). 
Conclusion: This study supports the removal of mitotic count from staging but shows that 
its scoring is substantially affected by interobserver variation, suggesting that more 
prescriptive guidelines might have a beneficial impact on its prognostic value.
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Introduction
Malignant melanoma is an aggressive skin cancer where clinical stage at diagnosis is a key 
determinant of outcome. Most patients with early stage remain disease-free while 
outcome is poor for advanced disease. The American Joint Committee on Cancer (AJCC8) 
and the Union for International Cancer Control (UICC8) version 8 schemes are 
internationally recognised for staging and there are national guidelines that are used to 
help histopathologists apply the scheme in a consistent manner and foster its widespread 
adoption, such as those used in the UK 1 and USA 2.
One important change with the latest 8th version of staging (AJCC8) was the removal of 
mitotic count as a pT1 staging feature, where it had been used previously to distinguish 
pT1a from pT1b melanoma. Its value had been called into question 3, 4 and notably 
tumours classed as pT1b on the basis of mitoses had better outcomes than thicker pT1a 
melanomas in some analyses 5, 6. In particular, the validity of the hotspot mitotic counting 
method has been questioned because there is evidence that the distribution of mitoses in 
a histological section follows a form of Poisson distribution 7. This would mean that finding 
a single mitosis in melanomas with low numbers of mitotic figures might reflect chance 
rather than biology. Instead of mitotic count, AJCC8 distinguishes non-ulcerated pT1a 
from pT1b using a Breslow thickness (BT) cut point of < 0.8 mm 8. 
The jettisoning of mitotic count shows that the staging scheme remains in a state of 
evolution in the quest for optimal prediction and begs the question about why prognostic 
features that have apparent sound biological basis can be deemed unfit for purpose. One 
issue is whether the guidelines are sufficiently precise for histopathologists to reliably 
measure a feature while controlling for interobserver discrepancy. Our primary study aim 
was to determine whether the prognostic value of a single mitosis for pT1 melanoma was 
diminished because the change between 0 and 1 mitosis per mm2 was too precise 
compared to the level of interobserver variation in mitotic count scoring. We sought to 
analyze this by first assessing whether the 0 versus 1 mitosis cut point had a significant 
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what extent those findings might have been affected by poor agreement between 
observers. In other words, whether "signal" was swamped by "noise". We also gathered 
data on other staging features, so our secondary research aims were to assess 
interobserver agreement for these, namely Breslow thickness, ulceration and 
microsatellitosis. The driving force behind this study was to determine whether guidance 




For Kaplan-Meier analysis of a single mitosis in pT1 melanoma a starting cohort of 970 
cutaneous melanoma from the archives of the University Hospitals of Leicester NHS trust 
was used representing cases diagnosed between January 1st 2004 and December 31st 
2011. The cases have been described previously 9. From these, a set of 476 was identified 
that were ≤ 1 mm thick, with either 0 or 1 mitoses per mm2 and without ulceration. For 
mitotic count agreement analysis we chose a different subset of cases that were between 
0.9 and 1.0 mm thick with hotspot mitotic counts in the original pathology report ranging 
from 0 to 4 mitoses per mm2, with 2 of each count to yield 10 cases in total.
Histological feature agreement
To analyze mitotic count agreement, all of the original glass slides used by the reporting 
histopathologists were available to the participants, including deeper levels and extra 
stains. These were anonymized and analyzed in turn by each of 10 United Kingdom expert 
dermatopathologists, all of whom were experienced practitioners. The histopathologists 
were from outside of the coordinating centre, Leicester, where the original report was 
generated. Each participant reviewed slides independently. Each assessed the features 
according to his/her own experience and interpretation of published criteria. All 
participants were allocated a unique code, rendering them anonymous. A simple form 









This article is protected by copyright. All rights reserved
melanoma reporting 1 was created and the histopathologists were asked to document for 
each case: presence of dermal invasion, histological subtype, Breslow thickness, 
ulceration, mitotic index, lymphovascular invasion, microsatellite metastasis, margin 
involvement, neurotropic/perineural invasion, growth phase, tumour-infiltrating 
lymphocytes, regression and T category. The histopathologists were not informed that 
mitotic count agreement was the focus of the study and they were instructed to report 
each case as if it was part of their diagnostic workload to minimise bias away from routine 
practice. Research ethics committee approval was obtained for the use of tissue (IRAS ID 
220400). 
In order to assess agreement about individual putative mitotic figures, a printed booklet 
was created from a set of PowerPoint slides containing 20 putative mitotic figures that 
were photographed at low, medium and high power. This was sent to each participating 
pathologist with a response sheet. Eight pathologists were available for scoring. The 
participants were given the instruction, “For each slide that follows please answer the 
following three questions about the potential mitotic figure near to the red arrow. 1. Is 
this a mitotic figure? 2. Is the potential mitotic figure in a melanocyte? 3. Is the potential 
mitotic figure in the dermis?” The PowerPoint file used to generate the booklet is 
provided as supplementary material (Supplementary_file.pdf). 
Statistical analyses
Statistical analysis was performed in R version 3.2.0 10.The baseline data table for the 
survival analysis cases was created using the “tableone” package 11. Survival analyses were 
performed with the “survival” package 12 and Kaplan Meier plots were generated with the 
“survminer” package 13. Time to event analysis was performed for overall survival (OS), 
melanoma specific survival (MSS) and metastasis-free survival (MFS). The date of diagnosis 
was the date of primary melanoma sample accession in the pathology database. For OS, 
failure was death from any cause. For MSS death from melanoma was considered as failure 
while death from another cause was regarded as censoring. For MFS, the event was the 
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Kaplan Meier method and log rank tests were used to compare survival curves. Kappa 
statistics and intraclass correlation coefficients were calculated using the “irr” package 14. 
For the intraclass correlation coefficient, a two way model was used for absolute 
agreement. For multirater kappa statistic, Fleiss's kappa was used. To determine whether 
systematic differences were present between rater scores, a Friedman test was used. For 
statistical tests, a two-tailed p value of < 0.05 was regarded as significant.
Results
Prognostic value of a single mitosis in thin melanoma
We first determined whether a single mitosis had prognostic value in pT1 melanoma using 
a single centre cohort of 476 melanomas. The baseline features are shown in Table 1. This 
series had a mean survival of 76 months and only 10.5% of cases died, reflecting the good 
survival for patients with thin melanoma. The median mitotic count was 0 per mm2.  
Kaplan Meier plots showed substantial overlap of the 0 versus 1 mitosis mm2 survival 
curves for OS and MSS and a log rank test revealed no significant difference. In contrast, 
for MFS patients with 1 mitosis per mm2 had worse outcome (Chisq= 14.1 on 1 degree of 
freedom, p < 0.001). It should be noted that there were only 7 events for MSS, which puts 
a substantial limit on statistical power. These findings are shown in Figure 1A-C.  The 
Kaplan Meier plots represent a univariable analysis of the association of a single mitosis 
with outcome, but by limiting the analysis to cases with Breslow thickness , the  ≤ 1.0mm
analysis was in essence stratified by thickness. Nevertheless, the mitotic count might still 
be confounded by thickness even within this stratum of thin melanomas. To assess this for 
the only significant univariable outcome, MFS, a Cox PH model was fitted to the data 
entering mitotic count (0 or 1) and Breslow thickness as covariables. The adjusted hazard 
ratio for mitotic count was 8.11 (confidence interval 2.49 to 26.45), p = 0.00052. This 
confirmed the prognostic value of mitotic count for predicting MFS. Breslow thickness was 
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The effect of interobserver variation on mitotic count scoring
We next sought to determine whether interobserver variation might dilute the prognostic 
association of 0 versus 1 mitosis per mm2 in T1 melanomas, which had previously been 
used to distinguish T1a and T1b. A series of melanomas was selected that were either 0.9 
or 1.0 mm Breslow thickness, comprising two cases each with mitotic counts of 0, 1, 2, 3 
and 4 based on the original surgical pathology report, yielding a total of 10 melanomas. In 
particular, we selected cases at the top of the pT1 Breslow thickness range because we 
wanted to avoid "micro-invasive" melanomas, i.e. those with such scanty melanoma cells 
in the dermis that mitotic count agreement would be virtually assured. It could be argued, 
therefore, that this set of melanomas is enriched for the ones that are most difficult for 
mitotic count scoring. The features of these melanomas are shown in Figure 2. The mitotic 
count was independently scored using the hotspot method by 10 United Kingdom expert 
dermatopathologists. The results are shown in Figure 3A. The ICC for mitotic count was 
0.58, indicating moderate agreement 15. Only 2 of the 10 melanomas showed complete 
agreement between histopathologists about whether the lesion had 0 versus 1 or more 
mitoses per mm2 (case 1 and 10). There was marked variability in the sum of mitotic 
figures across all 10 cases per histopathologist, with histopathologists 1 to 10 finding 11, 
15, 15, 11, 16, 3, 17, 20, 28, and 11 mitoses respectively. Thus, histopathologist 6 found 
only 3 mitoses across the 10 cases while histopathologist 9 found 28, representing more 
than 9x difference. A Friedman matched samples non-parametric ANOVA revealed 
evidence of a systematic difference between dermatopathologists (chi-squared = 25.1, df 
= 9, p-value = 0.003).
Agreement for individual mitotic figure recognition
So far, the assessment of mitotic count was on a per melanoma basis. However, in any 
given melanoma there are several opportunities for disagreement to occur, e.g. 
histopathologists may choose different slides or different regions within the same slide for 
counting. Even once a potential mitotic figure is found, a histopathologist must decide if it 
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photomicrographs of 20 possible mitotic figures at low, medium and high power and asked 
histopathologists 3 questions: (1) is the feature a mitotic figure? (2) Is the feature in a 
melanocyte? (3) Is the feature in the dermis? If the answers to questions 1-3 were yes, 
then this qualified as a mitotic figure. Figure 4A shows the overall yes/no answer (i.e. all 
of 1-3 = yes or any of 1-3 = no). The multi-rater kappa for overall yes/no was 0.54, 
representing moderate agreement. Figure 4B-I reveals exactly how any non-qualifying 
putative mitotic figures failed for each of the 8 participating histopathologists.  Thus, all 
agreed that putative mitotic figure 3 did not qualify for scoring, yet the reason behind this 
differed. Histopathologist 4 did not think it was a mitosis, while every other 
histopathologist did. Histopathologists 3 and 5 thought this feature was in the dermis 
while none of the others did. These data provide deeper insight into disagreement than 
analysis merely on a per melanoma basis. Examples of putative mitotic figures are shown 
in Figure 5, which are taken from the booklet given to each participating pathologist.
Agreement for other AJCC-relevant features
The 10 cases that were selected and specifically tailored towards analysis of mitotic 
counts were also used to gather data on other AJCC-relevant features. We therefore also 
asked each histopathologist to score Breslow thickness (mm), ulceration (present/absent) 
and microscopic satellites (present/absent) for each case. The findings (including mitotic 
count) are summarised in Table 2 and graphically in Figure 3B and 3C. No histopathologists 
reported the presence of microscopic satellites for any of the 10 melanomas, representing 
complete agreement, and this feature was not analysed further. Breslow thickness showed 
important differences between histopathologists. Five histopathologists called case 3 in-
situ melanoma while the other 5 all found the thickness to be at least 0.8 mm. This case 
featured expansile junctional nests that made it difficult to determine which cells were 
truly dermal (Figure 6A). This perhaps explains why no measurements fell between 0 mm 
and 0.8 mm, as histopathologists were forced to make an all-or-none decision, and this 
would also have influenced mitosis scores, since only dermal mitoses should be counted. 
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case invasive. The interobserver discrepancies were reflected in an intraclass correlation 
coefficient of 0.41, indicating moderate agreement for this most important histological 
prognostic feature. There was also a systematic difference between histopathologists, 
with some reporting greater Breslow thickness across all cases (Friedman chi-squared = 
17.9, df = 9, p-value = 0.037).Thus, histopathologist 3 had a mean Breslow thickness of 
0.85 mm while histopathologist 6 had a mean of 0.70. It was also notable that one 
histopathologist measured case 4 as 1.14 mm, which crosses a T stage boundary from pT1 
to pT2. These data additionally show the potential for staging accuracy problems with the 
AJCC8 cut point of 0.8 mm for pT1a and pT1b, because every single case had a range of 
scores that crossed this staging boundary. Ulceration was only identified in 2 of 10 cases. 
Three histopathologists deemed ulceration to be present in case 1 and five in case 3, so 
even for these cases there was no agreement. All histopathologists agreed that there was 
no ulceration in the remaining 8 cases. Both of these discrepant cases had issues that 
might have affected interpretation. There was surface disruption in case 1 (Figure 6B) and 
there was only a very small focus of epidermal loss in case 3 (Figure 6C and 6D). The 
overall multirater kappa agreement score was 0.31, indicating fair agreement 15.
Discussion
We found moderate interobserver agreement for hotspot mitotic figure scoring in 
melanoma cases. To our knowledge, this is the first time that agreement about individual 
putative mitotic figures has been assessed. Moderate agreement was found again. In 
addition, we found that a cut point of 0 versus 1 mitoses per mm2 using the hotspot 
method had limited prognostic value in 476 thin melanomas, supporting the removal of 
mitotic hotspot counting from AJCC7, but our findings raise the possibility that the 
prognostic value was limited because the true importance was overwhelmed by 
interobserver variation. In addition, we found that interobserver variation for Breslow 
thickness and ulceration has implications for AJCC8 staging.
Prognostic features related to AJCC staging have been studied previously. Mitotic counts 
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from various studies 17-19. The hotspot method was adopted because it was regarded as 
having better interobserver agreement 20 compared to earlier studies using non-hotspot 
methods 21-24. However, more recent studies have found that the hotspot method is also 
subject to discordance between observers 25-27 while others have found good agreement 28, 
29, indicating mixed support for hotspot scoring, but it should be noted that some of these 
studies compared melanoma prognostic features between original pathology reports and 
those generated at referral centres, where cases may be more complex. Agreement 
studies on Breslow thickness have generally found strong agreement 20, 23, 28-31, although in 
one study 387 out of 588 cases (66%) had a revised Breslow thickness following review at a 
referral centre 27. Agreement studies for ulceration have also been performed, usually 
with kappa scores more than 0.8 20, 29, 31 indicating excellent agreement, but a few studies 
showed weaker agreement 23, 30, 32.
The level of interobserver discordance that we found for mitotic counting is not surprising 
if one considers how opportunities for subjectivity can arise, and we speculate that this 
relates to four questions that each histopathologist must consider: Where in the section(s) 
should the hotspot count be done?  Is a putative mitotic figure genuine? Is the putative 
mitotic figure in a melanocyte? Is the putative mitotic figure in a dermal location? In our 
study, there was ample opportunity for histopathologists to perform hotspot counts in 
different fields to each other because we provided every one of the glass slides used by 
the original reporting histopathologist, comprising sections from each block and all deeper 
levels. However, our study did not capture this variable. With regard to deciding if a 
mitotic figure was dermal, case 3 was informative because it had expansile junctional 
nests that could be regarded as not at all or partially dermal, necessitating a judgement 
about both tumour thickness and mitosis location, presumably based on participant 
interpretation of relevant guidelines, literature and clinical experience. This probably 
reflected why the same case was either called in-situ or 0.8 mm thick or more, with no 
intermediate measurements. Cases 1 and 3 provided insight into discrepancy regarding the 
reporting of ulceration. It seems likely that case 1 necessitated a decision about whether 
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required judgement about whether genuine biological ulceration was present or a tiny 
erosion due to excoriation. Alternatively, it may not have been seen.
In the light of these observations, we proceeded to explore how discrepancies arose at the 
level of individual putative mitotic figures in contrast to the global assessment across a 
whole melanoma. We used a set of photomicrographs of putative mitotic figures and were 
able to identify more precisely how discrepancy occurred. To our knowledge, this sort of 
analysis has not been done before in cutaneous melanoma. 
Our overall findings suggest that mitotic counting could be improved with more robust 
guidelines. Such guidelines would need to take into account the fact that mitotic figures 
in a section follow a form of Poisson distribution7, and so an average rather than a hotspot 
count might have better prognostic value. Guidelines should also include clearer advice 
about default histological locations for scoring mitoses. For example, some modification of 
the approach described by Vollmer, where the average count across the full breadth of 
the section containing the deepest cell was used 7. Agreement might also be improved by 
limiting the choice of slide, for example by limiting the count to the same glass slide 
where BT is measured. With regard to expansile superficial nests that could be either 
junctional, dermal or partly both, it may be important to revisit the concept of variant 
vertical growth phase 33 and to formulate clear rules about whether or not these should be 
routinely considered for Breslow thickness measurement (assuming no deeper cells are 
found) and whether or not to count contained mitotic figures. The medical literature is 
focused on high-tech molecular biomarkers that typically incur cost and have technical 
barriers to clinical adoption, but it may be that merely improving the guidelines for 
scoring simple histological features could be a truly low cost way to enhance melanoma 
outcome prediction.
In conclusion, this study supports the removal of mitotic count from AJCC7 staging. 
However, our findings suggest that the value of mitotic counting is substantially affected 
by interobserver variation and raises the possibility that more prescriptive guidelines for 
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signal to noise ratio. As for assessment of other features, it should be emphasized that this 
is a biased set of cases designed for the specific purpose of assessing mitotic counts in 
thicker T1 category melanomas. However, within these limits we additionally found that 
the core staging features of Breslow thickness and ulceration were open to subjective 
interpretation. Importantly, these results provide insight into potential problems with 
AJCC8 staging, namely disagreement about the Breslow thickness-based 0.8 mm cut point 
for pT1 staging. This has important implications for sentinel lymph node biopsy eligibility.
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Table 1. The baseline features of 476 melanomas ≤ 1.0 mm (excluding ulcerated cases).
n = 476 n (%)
Gender = Male (%) 227 (47.7)
Age (mean (sd)) 56.40 (16.28)
Time to metastasis (mean (sd)) 75.50 (26.17)
Time to death (mean (sd)) 76.41 (25.18)
Dead (%) 50 (10.5)
Site (%)
   Acral 17 (3.6)
   Head & neck 81 (17.0)
   Lower limb 121 (25.4)
   Trunk 170 (35.7)
   Upper limb 87 (18.3)
Type (%)
   SSMM 400 (84.0)
   LMM 42 (8.8)
   ALMM 12 (2.5)
   NMM 7 (1.5)
   Desmoplastic 1 (0.2)
   Spitzoid 1 (0.2)
   Unknown 13 (2.7)
Breslow (mean (sd)) 0.55 (0.20)
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n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 10
Mitoses (per mm2)           
    Median 3.5 0 0 2 0 1 0 0 4.5 1.5
    Minimum 2 0 0 0 0 0 0 0 0 1
    Maximum 8 1 3 6 1 2 1 1 11 2
Breslow (mm)           
    Median 0.91 0.82 0.40 1.07 0.80 0.80 0.75 0.45 0.88 0.84
    Minimum 0.8 0.7 0 0.1 0.75 0.7 0.5 0 0.8 0.75
    Maximum 0.97 0.98 0.94 1.14 0.9 0.95 0.9 0.8 0.9 0.95
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Figure legends
Figure 1. Kaplan Meier plots of pT1 melanomas with hotspot mitosis count of 0 or 1. 
Ulcerated melanomas were excluded from the analysis. (A) OS, (B) MSS, (C) MFS.
Figure 2. Melanoma cases used for mitotic count agreement analysis. TILs = tumour-
infiltrating lymphocytes; LVI = lymphovascular invasion; PNI = Perineural invasion.
Figure 3. Mitotic count, Breslow thickness and ulceration agreement on 10 melanomas for 
each of 10 UK histopathologists.
Figure 4. Histopathologist agreement for categorizing potential mitotic figures. (A) 
Overall yes/no agreement. (B - I) Putative mitotic figures for 8 pathologists, P-1 to P-8.
Figure 5. Examples of putative mitotic figures from three cases, each taken from the 
booklet used by participating histopathologists for scoring. Case 1 was agreed by all 
participants to show a mitotic figure. Cases 13 and 16 showed disagreement. The number 
of participants saying yes to questions 1-3 are shown for each case: Is the feature a 
mitosis? Is the feature in a melanocyte? Is the feature in the dermis? Only a yes to all 3 
questions results in a feature being labelled as a mitotic figure. LP = low power, MP = 
medium power, HP = high power.
Figure 6. Discrepant cases for AJCC8 staging features. Case 3 had epidermal acanthosis 
making assessment of mitotic figure location in junctional versus invasive cells difficult 
and also causing problems for measuring Breslow thickness (A). Case 1 caused 
disagreement about ulceration because of surface disruption at arrows (B). Case 3 had 
only a very focal area of epidermal loss at arrows (C), with magnified view of dashed box 
(C).
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